BÜHLMANN Laboratories AG

medical devices

About

BÜHLMANN Laboratories AG is a Swiss company founded in 1976, based in Schönenbuch near Basel. It specializes in the design, development, manufacture, and global sale of in vitro diagnostic (IVD) products and kits. The company is recognized as a leader in specialty diagnostics, focusing on areas such as inflammation, cellular allergy, neuroimmunology, clinical chemistry, and chronobiology. BÜHLMANN offers a diverse range of diagnostic assays and instruments, including the Quantum Blue® line for detecting calprotectin, a biomarker for gastrointestinal inflammation. Their product offerings also include the Flow CAST® allergy assay and various tests for autoimmunity and neuroimmunology. The company serves clinical laboratories, hospitals, research institutions, and healthcare providers worldwide, emphasizing high-quality and innovative solutions. In 2024, BÜHLMANN was acquired by KLAR Partners, which aims to enhance the company's growth and maintain its commitment to innovation in the IVD market.

Technologies

Outlook MailChimp SPF Autotask WordPress.org Woo Commerce Mobile Friendly Google Font API Nginx Google Tag Manager Remote AI

Keywords

in vitro diagnostics therapeutic drug monitoring inflammatory disease monitoring allergy neuroimmunology medical equipment manufacturing home diagnostic devices laboratory diagnostics immuno turbidimetric assays calex cap collection set services amanitin support gastroenterology tests clinical chemistry b2c sample collection kits autoimmunity diagnostics calprotectin mrp8/14 autoantibodies cellular allergy diagnostics quantum blue reader pancreatic elastase gangliocombi mag autoimmune diagnostics immunoassays clinical chemistry reagents molecular diagnostics autoantibody assays pharmaceutical and medicine manufacturing anti-gm1 antibodies

Location

55 Baselstrasse, Schoenenbuch, Basel-Landschaft, Switzerland, 4124

Related Companies

Companies in the same industry